Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review

SIMPLE SUMMARY: Although immunotherapy has dramatically revolutionized non-small cell lung cancer (NSCLC) treatment, not all the patients will benefit from this innovative therapy. The identification of potential biomarkers able to predict efficacy and toxicity of immunotherapy represents an urgent...

Descripción completa

Detalles Bibliográficos
Autores principales: Indini, Alice, Rijavec, Erika, Grossi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070633/
https://www.ncbi.nlm.nih.gov/pubmed/33918661
http://dx.doi.org/10.3390/cancers13081794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070633/
https://www.ncbi.nlm.nih.gov/pubmed/33918661
http://dx.doi.org/10.3390/cancers13081794

Ejemplares similares